Pfizer and BioNTech announced Friday they have submitted an application for full FDA approval of their COVID-19 vaccine for people ages 16 and older.
Like other COVID-19 vaccines available in the U.S., Pfizer-BioNTech is currently being administered under an emergency use authorization. In the midst of a pandemic, the FDA said it was more important to get vaccines to people quickly.
This would make Pfizer’s vaccine the first in the U.S. to be assessed for full FDA approval.
It is unclear how long the review will take, but Pfizer’s CEO Albert Bourla spoke of “the goal of securing full regulatory approval of the vaccine in the coming months,” according to a prepared statement.
After trials and 134 million shots, the vaccine has been shown to safely and effectively prevent COVID-19, and no additional safety issues have come up since the vaccine was authorized, according to the companies and periodic safety reviews by the Centers for Disease Control and Prevention.
Experts say the FDA approval could reduce vaccine hesitancy and empower employers to require their workers to get vaccinated.
Also in the news:
►India recorded a single-day high in new coronavirus cases on Friday. The embattled country recorded 414,188 cases in a single day, a new global high. The country also reported 3,915 additional deaths, and the official daily death count has stayed over 3,000 for the past 10 days.
►As the Tokyo Olympics near, Japan has extended its state of emergency in the city and other areas through May 31 due to COVID-19. Protests have been planned over a possible visit by the Olympics chief.
►The pace of the U.S. immunization effort is slowing with inoculations retreating more than 40% from its peak on April 10 of 4.6 million daily shots. Public health agencies are having to work harder to get shots in arms as they manage declining demand. The outreach efforts that will be critical to meet President Joe Biden’s new goal of 70% of Americans getting at least one shot by July 4.
►”Vax Live: The Concert to Reunite the World,” an event with Jennifer Lopez, Eddie Vedder, J Balvin and H.E.R., among other artists and celebrities, will air Saturday night. The event aims to encourage people to get vaccinated and to persuade world leaders and corporations to make COVID-19 vaccines available worldwide. It was taped Sunday, and hourlong edition will air on various networks on Saturday night. Read more here.
►Initial analysis of Phase 2/3 testing of Moderna’s vaccine in adolescents 12 to 17 years showed vaccine effectiveness of 96%, the company says. The vaccine was “generally well tolerated,” and there were no serious safety concerns identified thus far, the company said.
📈 Today’s numbers: The U.S. has 32.6 million confirmed coronavirus cases and 580,000 deaths, according to Johns Hopkins University data. The global totals: Over 156 million cases and 3.26 million deaths. More than 324.6 million vaccine doses have been distributed in the U.S. and nearly 252 million have been administered, according to the CDC. Almost 109 million Americans have been fully vaccinated.
📘 What we’re reading: Five months into the U.S. vaccination effort, one trend is holding across much of the nation: white people continue to be vaccinated at faster rates than Black and Hispanic people in most states.
Keep refreshing this page for the latest updates. Want more? Sign up for our Coronavirus Watch newsletter for updates to your inbox and join our Facebook group.
WHO panel authorizes emergency use of China’s Sinopharm vaccine
The World Health Organization on Friday authorized a COVID-19 vaccine by Chinese manufacturer Sinopharm for emergency use in a move that could help improve access to COVID-19 vaccines in poorer countries.
The authorization opens up the possibility that the Sinopharm vaccine may be included in the U.N.-backed COVAX program, which seeks to send free vaccines to 92 lower-income countries.
Little data on the Sinopharm vaccine has been made public, except for efficacy numbers for its two vaccines — one developed by the Beijing Institute of Biological Products and the other by the Wuhan Institute of Biological Products.
The vaccine is about 78% effective, though most study volunteers were younger than 60, according to an online WHO summary.
A group advising the agency said it was “very confident” the Sinopharm vaccine protects adults younger than 60 but had “very low confidence” in data available on people 60 years old and over, according to the Associated Press.
Job gains fall short of projections, unemployment rises
Job gains fell well short of projections with employers adding 266,000 jobs in April. Economists had estimated that 995,000 jobs were added last month, according to a Bloomberg survey.
The unemployment rate rose from 6% to 6.1% as a large increase in the labor force — the number of Americans working or looking for jobs — offset employment gains, the Labor Department said Friday.
The leisure and hospitality industry, which includes restaurants and bars, continued to recover, adding 331,000 jobs. As more schools reopened for in-person classes, public education added 31,000 jobs.
But other sectors had weak showings. Professional and business services lost 79,000 jobs, and retail lost 15,000 jobs.
Job growth is expected to boom in coming months as increased vaccinations lead more states to lift capacity limits at restaurants and other businesses. Oxford Economics reckons a record 8 million will be added this year.
— Paul Davidson
Anti-Asian American hate incidents continue to skyrocket
Violence against Asian Americans and Asians has grown despite increased national attention and political action against anti-Asian hate, experts say.
There was a more than 164% increase in anti-Asian hate crime reports to police in the first quarter of 2021 in 16 major cities and jurisdictions compared with last year, according to a report from the Center for the Study of Hate and Extremism at California State University, San Bernardino.
More than 6,600 hate incidents have been reported in the year after the pandemic began in the United States, Stop AAPI Hate announced this week. More than a third of those incidents were reported this March alone, according to the organization founded last year in response to increased targeting of Asian Americans and Pacific Islanders during the pandemic.
There have been several recent high-profile attacks. A man was arrested Tuesday after allegedly stabbing two Asian women in an unprovoked attack in downtown San Francisco. Over the weekend, two Asian women were attacked in New York City by a woman who demanded they remove their masks, then struck one of them in the head with a hammer, according to police.
The uptick in anti-Asian violence was first reported in March 2020 as COVID-19 began spreading across the nation and some politicians, including President Donald Trump, blamed China for the pandemic.
— N’dea Yancey-Bragg
Contributing: The Associated Press.
This article originally appeared on USA TODAY: COVID news, update: Pfizer applies for FDA approval; India case record